Pediatrix Medical Group (MD) Expected to Announce Earnings on Tuesday

Pediatrix Medical Group (NYSE:MD) is anticipated to announce its earnings results before the market opens on Tuesday, February 18th. Analysts expect the company to announce earnings of $0.37 per share and revenue of $486.22 million for the quarter.

Pediatrix Medical Group Trading Up 2.6 %

Shares of NYSE:MD opened at $13.99 on Tuesday. The stock has a market capitalization of $1.20 billion, a price-to-earnings ratio of -4.57, a PEG ratio of 1.38 and a beta of 1.57. Pediatrix Medical Group has a 1-year low of $6.62 and a 1-year high of $16.41. The company has a 50 day moving average price of $13.85 and a 200 day moving average price of $12.61. The company has a debt-to-equity ratio of 0.83, a quick ratio of 1.42 and a current ratio of 1.42.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the company. StockNews.com raised Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research report on Wednesday, January 22nd. Deutsche Bank Aktiengesellschaft boosted their price objective on Pediatrix Medical Group from $9.00 to $15.00 and gave the stock a “hold” rating in a report on Monday, November 4th. Jefferies Financial Group raised their target price on shares of Pediatrix Medical Group from $14.00 to $18.00 and gave the stock a “buy” rating in a report on Tuesday, November 5th. Macquarie began coverage on shares of Pediatrix Medical Group in a report on Monday, December 16th. They set an “outperform” rating and a $18.00 price target on the stock. Finally, Truist Financial decreased their price objective on shares of Pediatrix Medical Group from $16.00 to $15.00 and set a “hold” rating for the company in a research note on Monday, January 6th. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $16.25.

Insider Buying and Selling at Pediatrix Medical Group

In other Pediatrix Medical Group news, Director Mark S. Ordan sold 27,600 shares of the stock in a transaction on Wednesday, November 13th. The shares were sold at an average price of $15.35, for a total value of $423,660.00. Following the completion of the sale, the director now directly owns 138,683 shares of the company’s stock, valued at $2,128,784.05. This represents a 16.60 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 2.00% of the company’s stock.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.